Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Norvir (Ritonavir) Capsules & Solution, Abbott 20-659/S-030 & 20-945/S-013 9/10/03 9/25/03 9/25/03 | Norvir (Ritonavir) Abbott 20-659/S-027 & 20-945/S-008 3/14/02 3/29/02 3/14/02 | Norvir (Ritonavir) Abbott 20-659/S-026 & 20-945/S-007 3/6/01 4/26/01 | Norvir (ritonavir capsules) Soft Gelatin (ritonavir), Abbott 20-659/S-025 20-945/S-005 08/21/01 4/25/03 | Norvir (Ritonavir) Abbott 20-650/S-013 & 20-680/S-011 5/26/99 | Norvir Indications:Protease inhibitor that is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection. Norvir (Ritonavir) Abbott 20-945 6/29/99 | Norvir Indications: A protease inhibitor that is indicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection. Kaletra (lopinavir/ritonavir) Abbott Laboratories | NORVIR (ritonavir) capsules, Abbott Labs, Labeling Revision | NORVIR (ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, New Dosage Regimen | NORVIR (ritonavir) oral solution, Abbott Labs, Patient Population Altered | NORVIR (ritonavir) soft gelatin capsules, Abbott Labs, Patient Population Altered | KALETRA (lopinavir/ritonavir) tablets, Abbott Labs, Approval | NOVIR (ritonavir) capsules, Abbott Labs, Labeling Revision | NOVIR (ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) tablet, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Tablets, Abbott Labs, Labeling Revision | KALETRA (Lopinavir/ Ritonavir) Oral, Abbott Labs, Efficacy Supp. w/Clinical Data | KALETRA (Lopinavir/Ritonavir) Tablets, Abbott Labs, Efficacy Supp. w/Clinical Data | Kaletra (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ ritonavir) Tablets, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Capsules, Abbott Labs, Labeling Revision | NORVIR (ritonavir) Capsule, Abbott Labs, Labeling Revision | NORVIR (ritonavir) Oral Solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Tablets, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Oral Solution, Abbott Labs, New Dosage Regimen | KALETRA (lopinavir/ritonavir) Tablets, Abbott Labs, New Dosage Regimen | Norvir (ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Norvir (ritonavir) Capsules, Abbott Laboratories, Labeling Revision | KALETRA (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Patient Population Altered | KALETRA (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | NORVIR (ritonavir) Capsules, Abbott Laboratories, Labeling Revision | NORVIR (ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision | Lopinavir and Ritonavir Tablets, Matrix Laboratories, Ltd., Tentative Approval | Lopinavir and Ritonavir Tablets, Aurobindo Pharma, Ltd., Tentative Approval | KALETRA (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision | KALETRA (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Tablets, Abbott Laboratories, Efficacy Supplement with Clinical Data to Support | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Efficacy Supplement with Clinical Data to Support | Lopinavir and Ritonavir Tablets, Cipla Ltd., Tentative Approval | Norvir (ritonavir) Capsules, Abbott Laboratories, Labeling Revision | Norvir (ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Norvir (ritonavir) Tablets, Abbott Laboratories, Approval | Norvir (ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^                                                                                      A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | For Industry | DMF Index | Pharma Job Search | Pharma Company News © 2010 Betterchem.com